INOZYME PHARMA INC. - COMMON STOCK
1.9950
10-1月-25 16:45:00
15 分の遅延
株式
-0.8050
-28.75%
本日の幅
1.9700 - 2.7443
ISIN
N/A
ソース
NASDAQ
-
04 10 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the 2021 Cantor Virtual Global Healthcare Conference
22 9 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Q2 2021 Financial Results and Provides Business Highlights
11 8 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
04 8 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
21 7 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Appointment of Gayle Gironda as Senior Vice President, Human Resources
13 7 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
09 6 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Q1 2021 Financial Results and Provides Business Highlights
12 5 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
07 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the BofA Securities 2021 Virtual Healthcare Conference
06 5 2021 07:30:01 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Publishes Data Supporting INZ-701 as a Potential Treatment for ENPP1 Deficiency
29 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
08 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Expands its Scientific Advisory Board
01 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights
25 3 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
11 3 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer
04 2 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
04 1 2021 06:00:00 提供 Nasdaq GlobeNewswire